Register Login

Abiopharma

  • Home
  • About
  • Newsroom
  • Company List
  • Events
  • Automated Tools
  • Contact

News list

Avantor Inc. (AVTR)

  • Business News
  • April 29, 2026, 10:05 UTC
  • 1
  • 1 comments

Avantor, Inc. - Avantor® Reports First Quarter 2026 Results

Market reaction Comment Full text

AVANTOR, INC. (AVTR)

  • Business News
  • April 29, 2026, 10:05 UTC
  • 1
  • 1 comments

Avantor® Reports First Quarter 2026 Results

Market reaction Comment Full text

Avantor Inc. (AVTR)

  • Business News
  • April 29, 2026, 10:05 UTC
  • 1
  • 1 comments

Avantor® Reports First Quarter 2026 Results

Market reaction Comment Full text

BANK HAPOALIM B.M. (POLI)

  • Business News
  • April 29, 2026, 10:02 UTC
  • 1
  • 1 comments

Change in holdings of interested parties/officers

Market reaction Comment Full text

LEMONADE, INC. (LMND)

  • Business News
  • April 29, 2026, 10:01 UTC
  • 1
  • 1 comments

Lemonade Announces First Quarter 2026 Financial Results

Market reaction Comment Full text

TRI POINTE HOMES, INC. (TPH)

  • Business News
  • April 29, 2026, 10:00 UTC
  • 1
  • 1 comments

Tri Pointe Homes, Inc. Reports 2026 First Quarter Results

Market reaction Comment Full text

ALLOT LTD (ALLT)

  • Business News
  • April 29, 2026, 10:00 UTC
  • 0
  • 1 comments

Allot to Present at the 21st Annual Needham Technology, Media & Consumer Conference on May 13, 2026

Market reaction Comment Full text

SILGAN HOLDINGS INC (SLGN)

  • Business News
  • April 29, 2026, 10:00 UTC
  • 1
  • 1 comments

Silgan Announces First Quarter 2026 Results

Market reaction Comment Full text

COGNIZANT TECHNOLOGY SOLUTIONS CORP (CTSH)

  • Business News
  • April 29, 2026, 10:00 UTC
  • 1
  • 1 comments

Cognizant to Acquire Astreya, Deepening Its AI-First Managed Services Capabilities at Scale

Market reaction Comment Full text

HUTCHMED (CHINA) LTD (HCM)

  • Business News
  • April 29, 2026, 10:00 UTC
  • 0
  • 1 comments

HUTCHMED Announces NDA Acceptance in China with Priority Review Status and Breakthrough Designation for Sovleplenib for the Treatment of Warm Antibody Autoimmune Hemolytic Anemia

Market reaction Comment Full text
  • Previous
  • 83
  • 84
  • 85
  • 86
  • 87
  • Next

Search

News categories

  • Technical Exchange News(12156)
  • Event(5811)
  • SEC News(258060)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(152465)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin